192 related articles for article (PubMed ID: 30513408)
1. Disruption of a CD1d-mediated interaction between mast cells and NKT cells aggravates atherosclerosis.
Kritikou E; van Duijn J; Nahon JE; van der Heijden T; Bouwman M; Groeneveldt C; Schaftenaar FH; Kröner MJ; Kuiper J; van Puijvelde GHM; Bot I
Atherosclerosis; 2019 Jan; 280():132-139. PubMed ID: 30513408
[TBL] [Abstract][Full Text] [Related]
2. A CD1d-dependent lipid antagonist to NKT cells ameliorates atherosclerosis in ApoE-/- mice by reducing lesion necrosis and inflammation.
Li Y; Kanellakis P; Hosseini H; Cao A; Deswaerte V; Tipping P; Toh BH; Bobik A; Kyaw T
Cardiovasc Res; 2016 Feb; 109(2):305-17. PubMed ID: 26604037
[TBL] [Abstract][Full Text] [Related]
3. Ox-LDL-induced CD80
Wang Y; Zou Y; Jiang Q; Li W; Chai X; Zhao T; Liu S; Yuan Z; Yu C; Wang T
Am J Physiol Cell Physiol; 2024 Jun; 326(6):C1563-C1572. PubMed ID: 38586879
[TBL] [Abstract][Full Text] [Related]
4. CD1d-dependent activation of NKT cells aggravates atherosclerosis.
Tupin E; Nicoletti A; Elhage R; Rudling M; Ljunggren HG; Hansson GK; Berne GP
J Exp Med; 2004 Feb; 199(3):417-22. PubMed ID: 14744994
[TBL] [Abstract][Full Text] [Related]
5. Invariant Natural Killer T-Cells and Total CD1d Restricted Cells Differentially Influence Lipid Metabolism and Atherosclerosis in Low Density Receptor Deficient Mice.
VanderLaan PA; Reardon CA; Cabana VG; Wang CR; Getz GS
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540125
[TBL] [Abstract][Full Text] [Related]
6. Antigen-induced increases in pulmonary mast cell progenitor numbers depend on IL-9 and CD1d-restricted NKT cells.
Jones TG; Hallgren J; Humbles A; Burwell T; Finkelman FD; Alcaide P; Austen KF; Gurish MF
J Immunol; 2009 Oct; 183(8):5251-60. PubMed ID: 19783672
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of invariant V alpha 14 natural killer T cells decreases atherosclerosis in LDL receptor null mice.
Rogers L; Burchat S; Gage J; Hasu M; Thabet M; Willcox L; Ramsamy TA; Whitman SC
Cardiovasc Res; 2008 Apr; 78(1):167-74. PubMed ID: 18192239
[TBL] [Abstract][Full Text] [Related]
8. CD4+ natural killer T cells potently augment aortic root atherosclerosis by perforin- and granzyme B-dependent cytotoxicity.
Li Y; To K; Kanellakis P; Hosseini H; Deswaerte V; Tipping P; Smyth MJ; Toh BH; Bobik A; Kyaw T
Circ Res; 2015 Jan; 116(2):245-54. PubMed ID: 25398236
[TBL] [Abstract][Full Text] [Related]
9. CD1d mediates T-cell-dependent resistance to secondary infection with encephalomyocarditis virus (EMCV) in vitro and immune response to EMCV infection in vivo.
Ilyinskii PO; Wang R; Balk SP; Exley MA
J Virol; 2006 Jul; 80(14):7146-58. PubMed ID: 16809320
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between type II NKT cells and T cells leads to spontaneous chronic inflammatory liver disease.
Weng X; He Y; Visvabharathy L; Liao CM; Tan X; Balakumar A; Wang CR
J Hepatol; 2017 Oct; 67(4):791-800. PubMed ID: 28596110
[TBL] [Abstract][Full Text] [Related]
11. CD252 regulates mast cell mediated, CD1d-restricted NKT-cell activation in mice.
Gonzalez Roldan N; Orinska Z; Ewers H; Bulfone-Paus S
Eur J Immunol; 2016 Feb; 46(2):432-9. PubMed ID: 26564814
[TBL] [Abstract][Full Text] [Related]
12. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.
Nishimura T; Kitamura H; Iwakabe K; Yahata T; Ohta A; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nakui M; Sekimoto M; Koda T
Int Immunol; 2000 Jul; 12(7):987-94. PubMed ID: 10882410
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production.
Ikarashi Y; Mikami R; Bendelac A; Terme M; Chaput N; Terada M; Tursz T; Angevin E; Lemonnier FA; Wakasugi H; Zitvogel L
J Exp Med; 2001 Oct; 194(8):1179-86. PubMed ID: 11602646
[TBL] [Abstract][Full Text] [Related]
14. ZBTB7B (Th-POK) regulates the development of IL-17-producing CD1d-restricted mouse NKT cells.
Enders A; Stankovic S; Teh C; Uldrich AP; Yabas M; Juelich T; Altin JA; Frankenreiter S; Bergmann H; Roots CM; Kyparissoudis K; Goodnow CC; Godfrey DI
J Immunol; 2012 Dec; 189(11):5240-9. PubMed ID: 23105140
[TBL] [Abstract][Full Text] [Related]
15. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
[TBL] [Abstract][Full Text] [Related]
16. Mast cell deficiency attenuates progression of atherosclerosis and hepatic steatosis in apolipoprotein E-null mice.
Smith DD; Tan X; Raveendran VV; Tawfik O; Stechschulte DJ; Dileepan KN
Am J Physiol Heart Circ Physiol; 2012 Jun; 302(12):H2612-21. PubMed ID: 22505639
[TBL] [Abstract][Full Text] [Related]
17. IFN-γ production downstream of NKT cell activation in mice infected with influenza virus enhances the cytolytic activities of both NK cells and viral antigen-specific CD8+ T cells.
Ishikawa H; Tanaka K; Kutsukake E; Fukui T; Sasaki H; Hata A; Noda S; Matsumoto T
Virology; 2010 Nov; 407(2):325-32. PubMed ID: 20855097
[TBL] [Abstract][Full Text] [Related]
18. Natural killer T cells in atherosclerosis.
Getz GS; Reardon CA
Nat Rev Cardiol; 2017 May; 14(5):304-314. PubMed ID: 28127028
[TBL] [Abstract][Full Text] [Related]
19. CD1d highly expressed on DCs reduces lung tumor burden by enhancing antitumor immunity.
Li Y; Zhao C; Liu J; Lu Z; Lu M; Gu J; Liu R
Oncol Rep; 2019 May; 41(5):2679-2688. PubMed ID: 30864713
[TBL] [Abstract][Full Text] [Related]
20. Ascites specific inhibition of CD1d-mediated activation of natural killer T cells.
Webb TJ; Giuntoli RL; Rogers O; Schneck J; Oelke M
Clin Cancer Res; 2008 Dec; 14(23):7652-8. PubMed ID: 19047090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
